The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Activated Injectable Vitamin D and Hemodialysis Survival: A Historical Cohort Study
Abstract
Patients with ESRD commonly experience secondary hyperparathyroidism, a condition primarily managed with activated injectable vitamin D. The biologic effects of vitamin D, however, are widespread, and it is possible that activated injectable vitamin D alters survival in ESRD. This hypothesis was tested in a historical cohort study of incident hemodialysis patients who lived throughout the United States between January 1996 and December 1999. The primary outcome was 2-yr survival among those who survived for at least 90 d after initiation of chronic hemodialysis. During this period, 51,037 chronic hemodialysis patients survived for at least 90 d from the initiation of hemodialysis, and in the ensuing 2 yr, 37,173 received activated injectable vitamin D and 13,864 did not. At 2 yr, mortality rates were 13.8/100 person-years in the group that received injectable vitamin D compared with 28.6/100 person-years in the group that did not (P < 0.001). Cox proportional hazards analyses adjusting for several potential confounders and examining injectable vitamin D therapy as a time-dependent exposure suggested that compared with patients who did not receive injectable vitamin D, the 2-yr survival advantage associated with the group that did receive injectable vitamin D was 20% (hazard ratio, 0.80; 95% confidence interval, 0.76 to 0.83). The incidence of cardiovascular-related mortality was 7.6/100 person-years in the injectable vitamin D group, compared with 14.6/100 person-years in the non-vitamin D group (P < 0.001). The benefit of injectable vitamin D was evident in 48 of 49 strata examined, including those with low serum levels of intact parathyroid hormone and elevated levels of serum calcium and phosphorus, situations in which injectable vitamin D is often withheld. Repeating the entire analysis using marginal structural models to adjust for time-dependent confounding by indication yielded a survival advantage of 26% (hazard ratio, 0.74; 95% confidence interval, 0.71 to 0.79) associated with the injectable vitamin D group. In this historical cohort study, chronic hemodialysis patients in the group that received injectable vitamin D had a significant survival advantage over patients who did not. Randomized clinical trials would permit definitive conclusions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A structural approach to selection bias
Hernán, M. A., Hernández-Díaz, S., & Robins, J. M. (2004) · Epidemiology · doi:10.1097/01.ede.0000135174.63482.43 · Cited by 2,844
Self-citationGoodman, W. G., Goldin, J., Kuizon, B. D., Yoon, C., Gales, B., Sider, D., Wang, Y., Chung, J., Emerick, A., Greaser, L., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005183422003 · Cited by 2,509
Oodman, W. I. G. G., Oldin, J. O. G., Uizon, D. K., Oon, C. H. Y., Ales, B. A. G., Ider, D. O. S., Ang, W. C., Oanie, J., Hung, C., Merick, A. L. E., et al. (2000) · Cited by 2,191
Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study
Hyppönen, E., Läärä, E., Reunanen, A., Järvelin, M.-R., & Virtanen, S. M. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06580-1 · Cited by 1,928
Hernán, M. Á., Brumback, B., & Robins, J. M. (2000) · Epidemiology · doi:10.1097/00001648-200009000-00012 · Cited by 1,782
Self-citation1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system
Li, Y. C., Kong, J., Wei, M., Chen, Z.-F., Liu, S. Q., & Cao, L.-P. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215219 · Cited by 1,625
Hypovitaminosis D in Medical Inpatients
Thomas, M. K., Lloyd-Jones, D. M., Thadhani, R. I., Shaw, A. C., Deraska, D. J., Kitch, B. T., Vamvakas, E. C., Dick, I. M., Prince, R. L., & Finkelstein, J. S. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803193381201 · Cited by 1,423
Self-citationBone metabolism and disease in chronic kidney disease
Eknoyan, G., Levin, A., & Levin, N. W. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00905-3 · Cited by 1,286
GANESH, S. K., STACK, A. G., LEVIN, N. W., HULBERT-SHEARON, T., & PORT, F. K. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v12102131 · Cited by 1,204
Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis
Block, G. A., Martin, K. J., de Francisco, A. L. M., Turner, S. A., Avram, M. M., Suranyi, M. G., Hercz, G., Cunningham, J., Abu-Alfa, A. K., Messa, P., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031633 · Cited by 1,139
Survival of Patients Undergoing Hemodialysis with Paricalcitol or Calcitriol Therapy
Teng, M., Wolf, M., Lowrie, E., Ofsthun, N., Lazarus, J. M., & Thadhani, R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022536 · Cited by 927
Self-citationCepeda, M. S. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg115 · Cited by 859 · cited 1×
“propensity score analysis could not be performed (28).”
BackgroundDIETARY VITAMIN D AND CALCIUM AND RISK OF COLORECTAL CANCER: A 19-YEAR PROSPECTIVE STUDY IN MEN
Garland, C., Barrett-Connor, E., Rossof, A., Shekelle, R., Criqui, M., & Paul, O. (1985) · The Lancet · doi:10.1016/s0140-6736(85)91082-7 · Cited by 718
Statistical Considerations in the Intent-to-Treat Principle
Lachin, J. M. (2000) · Controlled Clinical Trials · doi:10.1016/s0197-2456(00)00046-5 · Cited by 652 · cited 1×
“would have grossly misclassified patients’ exposure status (29).”
BackgroundIncreased incidence of hip fractures in dialysis patients with low serum parathyroid hormone
Coco, M., & Rush, H. (2000) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2000.19812 · Cited by 603
Matching to Remove Bias in Observational Studies
(2006) · Matched Sampling for Causal Effects · doi:10.1017/cbo9780511810725.007 · Cited by 600
Block, G. A., & Port, F. K. (2000) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(00)70064-3 · Cited by 594
Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure?
Zittermann, A., Schleithoff, S. S., Tenderich, G., Berthold, H. K., Körfer, R., & Stehle, P. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02624-4 · Cited by 536
Albert, C. M., Ma, J., Rifai, N., Stampfer, M. J., & Ridker, P. M. (2002) · Circulation · doi:10.1161/01.cir.0000017493.03108.1c · Cited by 533
Active Serum Vitamin D Levels Are Inversely Correlated With Coronary Calcification
Watson, K. E., Abrolat, M. L., Malone, L. L., Hoeg, J. M., Doherty, T., Detrano, R., & Demer, L. L. (1997) · Circulation · doi:10.1161/01.cir.96.6.1755 · Cited by 482
Timms, P. M. (2002) · QJM · doi:10.1093/qjmed/95.12.787 · Cited by 462
Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure
Rostand, S. G., & Drüeke, T. B. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00575.x · Cited by 419
A Crucial Role for the Vitamin D Receptor in Experimental Inflammatory Bowel Diseases
Froicu, M., Weaver, V., Wynn, T. A., McDowell, M. A., Welsh, J. E., & Cantorna, M. T. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0281 · Cited by 407
SCRAGG, R., JACKSON, R., HOLDAWAY, I. M., LIM, T., & BEAGLEHOLE, R. (1990) · International Journal of Epidemiology · doi:10.1093/ije/19.3.559 · Cited by 394
Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism
Sprague, S. M., Llach, F., Amdahl, M., Taccetta, C., & Batlle, D. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00878.x · Cited by 392
Vitamin D regulation of the renin–angiotensin system
Li, Y. C. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10343 · Cited by 355
Stevens, L. A., Djurdjev, O., Cardew, S., Cameron, E. C., & Levin, A. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000113243.24155.2f · Cited by 354
Shoji, T., Shinohara, K., Kimoto, E., Emoto, M., Tahara, H., Koyama, H., Inaba, M., Fukumoto, S., Ishimura, E., Miki, T., et al. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg513 · Cited by 351
Pathogenesis of secondary hyperparathyroidism
Slatopolsky, E., Brown, A., & Dusso, A. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.07304.x · Cited by 309
Park, C. W., Oh, Y. S., Shin, Y. S., Kim, C.-M., Kim, Y.-S., Kim, S. Y., Choi, E. J., Chang, Y. S., & Bang, B. K. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70260-x · Cited by 305
The association of nephrolithiasis with cystic fibrosis
Gibney, E. M., & Goldfarb, D. S. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00403-7 · Cited by 272
Sunlight, Vitamin D, and Ovarian Cancer Mortality Rates in US Women
LEFKOWITZ, E. S., & GARLAND, C. F. (1994) · International Journal of Epidemiology · doi:10.1093/ije/23.6.1133 · Cited by 271
Cole, S. R. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg206 · Cited by 270
25-hydroxyvitamin D-1α-hydroxylase in normal and malignant colon tissue
Tangpricha, V., Flanagan, J. N., Whitlatch, L. W., Tseng, C. C., Chen, T. C., Holt, P. R., Lipkin, M. S., & Holick, M. F. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04831-5 · Cited by 264
Ishimura, E., Nishizawa, Y., Inaba, M., Matsumoto, N., Emoto, M., Kawagishi, T., Shoji, S., Okuno, S., Kim, M., Miki, T., et al. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.0550031019.x · Cited by 236
ZALOGA, G. P., & CHERNOW, B. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-1-36 · Cited by 225
Association of Calcitriol and Blood Pressure in Normotensive Men
Kristal-Boneh, E., Froom, P., Harari, G., & Ribak, J. (1997) · Hypertension · doi:10.1161/01.hyp.30.5.1289 · Cited by 191
Elstner, E., Linker-Israeli, M., SAID, J. W., Umiel, T., Vos, S. D., Shintaku, I. P., Heber, D., Binderup, L., Uskoković, M. R., & Koeffler, H. P. (1995) · PubMed · Cited by 183
Ecologic Studies of Solar UV-B Radiation and Cancer Mortality Rates
Grant, W. B. (2003) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-55580-0_27 · Cited by 170
Normal myelopoiesis but abnormal T lymphocyte responses in vitamin D receptor knockout mice
O’Kelly, J., Hisatake, J., Hisatake, Y., Bishop, J. E., Norman, A. W., & Koeffler, H. P. (2002) · Journal of Clinical Investigation · doi:10.1172/jci12392 · Cited by 163
Haug, C. J., Muller, F., Aukrust, P., & Frøland, S. S. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/169.4.889 · Cited by 145
Cardiovascular calcification in patients with end-stage renal disease: A century-old phenomenon
Qunibi, W. Y., Nolan, C. A., & Ayus, J. C. (2002) · Kidney International · doi:10.1046/j.1523-1755.62.s82.15.x · Cited by 141
Kumagai, T., O’Kelly, J., SAID, J. W., & Koeffler, H. P. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.12.896 · Cited by 128
Determinants of coronary artery calcification in diabetics with and without nephropathy
Mehrotra, R., Budoff, M. J., Christenson, P., Ipp, E., Takasu, J., Gupta, A., Norris, K. C., & Adler, S. G. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00974.x · Cited by 105
Influence of Vitamin D Status on Insulin Secretion and Glucose Tolerance in the Rabbit*
Nyomba, B. L. G., Bouillon, R., & MOOR, P. D. (1984) · Endocrinology · doi:10.1210/endo-115-1-191 · Cited by 89
Therapeutic uses of vitamin D analogues
Brown, A. J. (2001) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2001.28111 · Cited by 87
ARTERIAL CALCIFICATION AFTER VITAMIN-D THERAPY IN HYPERPHOSPHATÆMIC RENAL FAILURE
Mallick, N. P., & Berlyne, G. M. (1968) · The Lancet · doi:10.1016/s0140-6736(68)91816-3 · Cited by 74
Dunlap, N., Schwartz, G. G., Eads, D., Cramer, S. D., Sherk, A. B., John, V. J., & Koumenis, C. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601161 · Cited by 73
Vitamin D receptor: Mechanisms for vitamin D resistance in renal failure
Dusso, A. (2003) · Kidney International · doi:10.1046/j.1523-1755.63.s85.3.x · Cited by 62
Yamamoto, T., Kozawa, O., Tanabe, K., Akamatsu, S., Matsuno, H., Dohi, S., Hirose, H., & Uematsu, T. (2002) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2632 · Cited by 60
Altered gene expression profile in the kidney of vitamin D receptor knockout mice
Li, X., Zheng, W., & Li, Y. C. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10547 · Cited by 56
Durakovic, C., Ray, S., & Holick, M. F. (2004) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.06002.x · Cited by 27
Effects of Massive Doses of Ergocalciferol Plus Cholesterol on Pregnant Rats and Their Offspring
Tshibangu, K., Oosterwijck, K., & Doumont-Meyvis, M. (1975) · Journal of Nutrition · doi:10.1093/jn/105.6.741 · Cited by 10
Cited by
Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
Gutiérrez, O. M., Mannstadt, M., Isakova, T., Rauh-Hain, J. A., Tamez, H., Shah, A., Smith, K., Lee, H., Thadhani, R., Jüppner, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706130 · Cited by 1,727
Self-citationLevin, A., Bakris, G. L., Molitch, M., Smulders, M., Tian, J., Williams, L. A., & Andress, D. L. (2007) · Kidney International · doi:10.1038/sj.ki.5002009 · Cited by 1,513
25-Hydroxyvitamin D Levels and the Risk of Mortality in the General Population
Melamed, M. L., Michos, E. D., Post, W., & Astor, B. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.15.1629 · Cited by 1,218
Gutierrez, O., Isakova, T., Rhee, E., Shah, A., Holmes, J., Collerone, G., Ju[Combining Diaeresis]ppner, H., & Wolf, M. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010052 · Cited by 921
Self-citationKalantar-Zadeh, K., Kuwae, N., Regidor, D. L., Kovesdy, C. P., Kilpatrick, R. D., Shinaberger, C. S., McAllister, C. J., Budoff, M. J., Salusky, I. B., & Kopple, J. D. (2006) · Kidney International · doi:10.1038/sj.ki.5001514 · Cited by 905
Metadata
- Authors
- Teng, M., Wolf, M., Ofsthun, M. N., Lazarus, J. M., Hernán, M. A., Camargo, C. A., & Thadhani, R.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2005-04
- Volume
- 16
- Issue
- 4
- Pages
- 1115-1125
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2113356410
- Cited by
- 782
- References
- 53
- FWCI
- 41.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.